Research Article
Prevalence of Clinically Significant Extraosseous Findings on Unenhanced CT Portions of 18F-Fluoride PET/CT Bone Scans
Table 1
Clinically significant extraosseous findings on CT of 18F-fluoride PET/CT.
| Patient no. | Age (y) | Sex | Type of cancer | Incidental findings by unenhanced CT |
| 1 | 54 | F | Breast cancer | Chest wall recurrence | 2 | 46 | F | Breast cancer | Pulmonary metastases | 3 | 71 | F | Breast cancer | Pulmonary metastases | 4 | 34 | F | Breast cancer | Axillary metastatic lymph nodes | 5 | 68 | F | Breast cancer | Pulmonary metastases and axillary metastatic lymph nodes | 6 | 34 | F | Breast cancer | Axillary metastatic lymph nodes | 7 | 47 | F | Breast cancer | Axillary metastatic lymph nodes | 8 | 50 | F | Breast cancer | Pulmonary metastases | 9 | 61 | F | Hepatocellular carcinoma | Pulmonary metastases | 10 | 68 | M | Hepatocellular carcinoma | Pulmonary metastases | 11 | 50 | M | Hepatocellular carcinoma | Pulmonary metastases | 12 | 48 | M | Hepatocellular carcinoma | Pulmonary and adrenal metastases | 13 | 51 | M | Buccal cancer | Cervical metastatic lymph nodes | 14 | 70 | F | Colon cancer | Pulmonary metastases | 15 | 59 | F | Endometrical cancer | Primary breast cancer with axillary metastatic lymph nodes | 16 | 36 | F | Ovarian cancer | Metastatic tumor of abdominal wall | 17 | 45 | M | Tongue cancer | Primary lung cancer with ipsilateral pulmonary metastases |
|
|
PET: positron emission tomography; CT: computed tomography.
|